Immunoregulatory therapy improves live birth in Th17/Treg-cell-elevated women with embryo transfer failure.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics(2023)

引用 0|浏览4
暂无评分
摘要
SynopsisImmunotherapy therapy can improve live birth rate in women with implantation failure. Patients may benefit more if they have elevated peripheral Th17/Treg ratio.
更多
查看译文
关键词
:cyclosporine,Th17 cell,Treg cell,hydroxychloroquine,immunoregulatory therapy,implantation failure,prednisone
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要